Glaukos Announces Participation in Wells Fargo Healthcare Conference
23 Agosto 2023 - 6:00AM
Business Wire
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical
technology and pharmaceutical company focused on novel therapies
for the treatment of glaucoma, corneal disorders and retinal
diseases, today announced that its management is scheduled to
participate in the Wells Fargo Healthcare Conference on Wednesday,
September 6, 2023, at 12:45 p.m. ET in Boston, MA.
A live and archived webcast for this event will be available in
the Investors section of the Glaukos website at
http://investors.glaukos.com.
About Glaukos
Glaukos (www.glaukos.com) is an ophthalmic medical technology
and pharmaceutical company focused on developing and
commercializing novel therapies for the treatment of glaucoma,
corneal disorders and retinal diseases. Glaukos first developed
Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the
traditional glaucoma treatment paradigm, launching its first MIGS
device commercially in 2012, and continues to develop a portfolio
of technologically distinct and leverageable platforms to support
ongoing pharmaceutical and medical device innovations. Products or
product candidates for each of these platforms are designed to
advance the standard of care through better treatment options
across the areas of glaucoma, corneal disorders and retinal
diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230823266984/en/
Chris Lewis Vice President, Investor Relations & Corporate
Affairs (949) 481-0510 clewis@glaukos.com
Glaukos (NYSE:GKOS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Glaukos (NYSE:GKOS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024